
Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer health care products, animal health care products and biopharmaceuticals. Its products are used in the treatment of central nervous system disorders, respiratory diseases, cardiovascular diseases, metabolic disorders, cancer, urological and viral conditions, among others. The company focuses on the research, development, manufacture and marketing of new drugs of therapeutic value for human and veterinary medicine. Boehringer operates globally through affiliates and is headquartered in Ingelheim am Rhein, Rheinland-Pfalz, Germany.
Boehringer Ingelheim GmbH-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Boehringer Ingelheim GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Boehringer Ingelheim GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 10
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 10
BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim 11
Boehringer Ingelheim GmbH-Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 16
Corporate Communications 18
Jun 10, 2016: Simone Menne - new Member of the Board of Managing Directors of Boehringer Ingelheim/Responsible for Corporate Board Division Finance 18
Other Significant Developments 19
Jun 08, 2017: Boehringer Ingelheim builds Digital Lab BI X with focus on innovative digital solutions in healthcare 19
Mar 02, 2017: Boehringer Ingelheim sponsors the new building of the Research Institute of Molecular Pathology in Vienna with EUR 52 million 20
Nov 30, 2016: Boehringer Ingelheim Selects ACD/Labs for International Deployment 21
Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Figures
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Boehringer Ingelheim GmbH, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
List of Tables
Boehringer Ingelheim GmbH, Medical Equipment, Key Facts, 2016 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Boehringer Ingelheim GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Boehringer Ingelheim GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Boehringer Ingelheim GmbH, Deals By Market, 2011 to YTD 2017 8
Boehringer Ingelheim GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 10
Ventana Medical Systems Enters Into Agreement With Boehringer Ingelheim For Companion Diagnostic Tests 10
BioGenes Enters Into Co-Development Agreement With Boehringer Ingelheim 11
Boehringer Ingelheim GmbH, Key Competitors 13
Boehringer Ingelheim GmbH, Key Employees 14
Boehringer Ingelheim GmbH, Other Locations 15
Boehringer Ingelheim GmbH, Subsidiaries 15
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Boehringer Ingelheim GmbH, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
For Regular updates on our latest research reports
Compare